Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
Sodium Glucose Co-Transporter 2 Inhibitors Use in Diabetic Patients with Cirrhosis Improves Liver-related Outcomes and Survival.
Journal: Clinical and translational gastroenterology
Published: March 30, 2026
A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.
Journal: Hepatology (Baltimore, Md.)
Published: January 22, 2026
Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications.
Journal: Alimentary pharmacology & therapeutics
Published: December 11, 2025
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.
Journal: Hepatology international
Published: November 26, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: Are We Doing Enough?
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: November 19, 2025
OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trial.
Journal: Hepatology (Baltimore, Md.)
Published: November 09, 2025
A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejection.
Journal: Hepatology communications
Published: October 20, 2025
Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low-Level Viraemia.
Journal: Alimentary pharmacology & therapeutics
Published: October 14, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
Journal: Gastroenterology
Published: October 08, 2025
The Interaction of Human Factors and Resistance-associated Substitutions in Hepatitis C Elimination.
The Interaction of Human Factors and Resistance-associated Substitutions in Hepatitis C Elimination.
Journal: Journal of clinical and experimental hepatology
Published: September 10, 2025
Last Updated: 09/26/2026